Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products. It also provides orthopedic products, including hip and shoulder joint reconstruction implants, plates, screws, and spinal devices, as well as instruments and delivery systems. In addition, the company provides products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products. Further, it offers cardiac and neuromodulation products, such as batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, implantable stimulation leads, and enclosures; pacemakers, implantable cardiac defibrillators, cardiac resynchronization therapy devices, implantable cardiac monitors, and other implantable devices; and neuromodulation medical devices. Additionally, it offers customized battery power and management systems, charging and docking stations, and power supplies for energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Frisco, Texas.
Industry, Sector and Symbol
Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:ITGR
CUSIP39153L10
Phone214-618-5243
Debt
Debt-to-Equity Ratio1.77%
Current Ratio2.55%
Quick Ratio1.46%
Price-To-Earnings
Trailing P/E Ratio19.52
Forward P/E Ratio16.89
P/E Growth1.11
Sales & Book Value
Annual Sales$1.46 billion
Price / Sales1.22
Cash Flow$6.5434 per share
Price / Cash8.52
Book Value$28.21 per share
Price / Book1.98
Profitability
EPS (Most Recent Fiscal Year)$2.81
Net Income$66.67 million
Net Margins4.56%
Return on Equity11.13%
Return on Assets3.17%
Miscellaneous
Employees9,700
Outstanding Shares32,010,000
